Wellmedr vs Telos Rx: Pricing, compounded meds, and policies
Quick verdict: Wellmedr emphasizes lower entry pricing and lifetime locked-in pricing with a 90-day money back claim, while Telos Rx lists semaglutide from $99/mo and tirzepatide from $139/mo with clinician review required. Choose based on whether locked pricing and shipping promises or the listed starting rates and provider messaging matter more to you.
See WellMedr plans and pricing
Wellmedr vs Telos Rx: head-to-head on the top differences
This comparison focuses on five distinctive differences supported by the source: starting price and plan details, pricing promises and refunds, compounded medication regulatory notes, shipping and timing claims, and clinician approval requirements. The providers are compared directly throughout.
1. Starting price and plan structure
Wellmedr lists GLP-1 plans starting at $89 per month and advertises semaglutide starting at $49 per month on certain monthly plans and a 1-Year Plan. Telos Rx lists semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with prices presented as dependent on plan and clinician approval. Both providers present per-month figures, but Wellmedr’s captured evidence shows a lower starting price in the materials provided.
2. Pricing promises, locked pricing, and cancellation
Wellmedr claims lifetime locked-in pricing and no dose-based price increases, plus promotional language captured on landing materials. Wellmedr also advertises a money back guarantee with the statement that if a customer does not lose weight in 90 days they will be refunded 100% of their money, as shown in the captured description. Telos Rx emphasizes prices stated as “as low as” amounts and notes that your price depends on your plan and that you may cancel anytime with no penalties in the captured evidence. Both providers note that pricing, eligibility and renewal terms may change.
3. Compounded medication status and regulatory notices
Both Wellmedr and Telos Rx state that semaglutide and tirzepatide are compounded medications when offered and that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr’s captured landing-page evidence explicitly states that compounded GLP-1 medications are offered exclusively from licensed U.S. pharmacies and repeats the regulatory notice. Telos Rx’s captured materials also state the compounded status and the same regulatory limitation.
Check WellMedr compounded medication info
4. Shipping, fulfillment, and guarantee claims
Wellmedr’s captured evidence includes claims of same-day review plus free overnight shipping, discreet guaranteed delivery and on-time refills guaranteed. Telos Rx’s captured materials do not provide verified shipping promises in the captured landing-page evidence; Telos Rx emphasizes treatment availability after licensed provider review and plan-dependent pricing. The presence of shipping and refill timing promises is a clear operational difference in the provided source material.
5. Clinician review and eligibility
Both providers state that treatment is available only when a licensed clinician determines it is medically appropriate and that medications are prescribed only after review by a US-licensed provider. Telos Rx repeatedly frames molecule selection as a US licensed provider decision and states “Pay $0 if not approved” in the captured messaging. Wellmedr also notes that all treatment plans require medical evaluation and clinician approval. Neither provider in the captured evidence guarantees outcomes and both caution individual results vary.
| Criteria | Wellmedr | Telos Rx |
|---|---|---|
| Starting price (captured) | $89/mo for GLP-1 plans; semaglutide shown as $49/mo on some monthly plans | Semaglutide as low as $99/mo; tirzepatide as low as $139/mo |
| Pricing promises | Lifetime locked-in pricing; no dose-based increases; money back claim for 90 days | Prices shown as “as low as” and plan dependent; cancel anytime no penalties |
| Compounded medication note | Compounded meds from licensed U.S. pharmacies; not FDA evaluated for safety or efficacy | Compounded medications; not FDA approved or reviewed for safety or effectiveness |
| Shipping and refills | Same-day review plus free overnight shipping; on-time refills guaranteed (captured) | Shipping and timing not verified in captured evidence |
| Clinician approval | Treatment requires medical evaluation and clinician approval | Prescription-only after review by a US licensed provider; pay $0 if not approved noted |
Confirm Telos Rx clinician review details
Summary and how to choose
Wellmedr vs Telos Rx hinges mainly on the captured starting price and promotional promises versus the listed “as low as” prices and provider messaging. Wellmedr’s evidence highlights lower captured starting prices, lifetime locked-in pricing, same-day review plus free overnight shipping and a 90-day refund claim in the captured materials. Telos Rx’s evidence highlights semaglutide from $99/mo and tirzepatide from $139/mo, clinician-driven molecule selection, and plan-dependent pricing with cancel anytime language. Both note that compounded medications are not FDA approved and that clinician approval is required.
Start with WellMedr plan details
Choose Wellmedr if you prioritize a lower captured starting price, lifetime locked-in pricing and the shipping and refund claims shown in the captured evidence. Choose Telos Rx if the presented starting rates of semaglutide from $99/mo or tirzepatide from $139/mo and explicit clinician-driven molecule selection align more closely with your priorities. Remember both providers state that compounded medications are not FDA approved and that treatment requires clinician review.